XNAS: CVKD
Cadrenal Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Cadrenal Therapeutics Inc is a late-stage biopharmaceutical company advancing novel therapies for life-threatening immune and thrombotic conditions. Its product candidate, CAD-1005, is a first-in-class selective 12-LOX inhibitor being developed to tr...
Read More
5.59
0.26
(4.88%)
58,415
XNAS Volume
XNAS 29 Apr, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Cadrenal Therapeutics Inc is on 08 May 2026 for the purpose of Cadrenal Therapeutics Inc First Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Bearish
Cadrenal Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..